Literature DB >> 28071618

Clinico-pathological factors affecting lymph node yield in Indian patients with locally advanced squamous cell carcinoma of mandibular Gingivo-Buccal sulcus.

S S Muttagi1, B R Patil2, A S Godhi3, D K Arora4, S R Hallikerimath5, A D Kale5.   

Abstract

AIM: Lymph node yield (LNY) is a valid marker of prognosis in oral cancer. Precise estimation of LNY in Indian patients with T3/T4 gingivobuccal sulcus squamous cell carcinoma (GBS-SCC) has not been well documented. Hence, the primary objective of the study was to determine the LNY in patients with T3/T4 SCC of mandibular GBS, and the secondary objective was to study the association of LNY with clinicopathological factors such as tumor thickness, histological differentiation, number of positive nodes, and extracapsular spread (ECS).
MATERIALS AND METHODS: Study patients comprised biopsy proven T3/T4 SCC of mandibular GBS that underwent unilateral surgery (composite or bite composite resection with level I to level V-neck dissection and pectoralis major flap reconstruction) at our center between January 2012 and October 2014. Grossing of surgical specimens was done as per the guidelines established by the Royal College of Pathologists (December 2009). The data were analyzed using SPSS software (22nd version) and Chi-square test.
RESULTS: The surgical specimens of 106 patients yielded 2329 lymph nodes with the mean LNY of 21.97 ± 5.57. Higher mean LNY of over 21 was significantly associated with ECS, number of positive nodes, delay in surgery over 15 days, skin involvement by the tumor, and presence of oral potentially malignant disorders.
CONCLUSION: With the single surgeon, pathologist and same surgical procedure, the mean LNY in Indian patients with T3/T4 SCC of mandibular GBS is 21.97 ± 5.57. Although clinicopathological factors affect the estimation of LNY, further studies are needed to validate the findings of this study.

Entities:  

Mesh:

Year:  2016        PMID: 28071618     DOI: 10.4103/0019-509X.197724

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  6 in total

1.  Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivo-buccal oral cancer.

Authors:  Debodipta Das; Arindam Maitra; Chinmay K Panda; Sandip Ghose; Bidyut Roy; Rajiv Sarin; Partha P Majumder
Journal:  NPJ Genom Med       Date:  2021-05-12       Impact factor: 8.617

2.  Lymph node yield as a prognostic factor in clinically node negative oral cavity squamous cell carcinoma.

Authors:  Ahmad A AlTuwaijri; Mohammed A Alessa; Alanoud A Abuhaimed; Reenad H Bedaiwi; Mohammad A Almayouf; Majed M Albarrak; Saleh F Aldhahri; Khalid H Al-Qahtani
Journal:  Saudi Med J       Date:  2021-12       Impact factor: 1.422

3.  Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer.

Authors:  Srija Mukhopadhyay; Sahana Ghosh; Debodipta Das; P Arun; Bidyut Roy; Nidhan K Biswas; Arindam Maitra; Partha P Majumder
Journal:  BMC Cancer       Date:  2020-12-14       Impact factor: 4.430

4.  Association of a multiple-step action with cervical lymph node yield of oral cancer patients in an Asian country.

Authors:  Ching-Chieh Yang; Bor-Hwang Kang; Wen-Shan Liu; Chun-Hao Yin; Ching-Chih Lee
Journal:  BMC Oral Health       Date:  2021-01-13       Impact factor: 2.757

5.  Log odds of positive lymph nodes as an independent predictor of overall survival in oral squamous cell carcinoma.

Authors:  Varuni Iyer; Kiran Kumar; Kaveri Hallikeri; Anil Kumar Desai; Niranjan Kumar; Srikant Natarajan
Journal:  J Oral Maxillofac Pathol       Date:  2021-01-09

6.  Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.

Authors:  Debodipta Das; Sahana Ghosh; Arindam Maitra; Nidhan K Biswas; Chinmay K Panda; Bidyut Roy; Rajiv Sarin; Partha P Majumder
Journal:  Clin Epigenetics       Date:  2019-12-03       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.